|
MechanismEPO receptor agonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
皮下注射长效人红细胞生长刺激素注射液治疗慢性透析肾性贫血的安全性、药代动力学及初步药效的临床研究
[Translation] Clinical study on the safety, pharmacokinetics and preliminary efficacy of subcutaneous long-acting human erythrocyte growth stimulating hormone injection in the treatment of chronic dialysis renal anemia
评价皮下注射长效人红细胞生长刺激素注射液治疗慢性透析肾性贫血的安全性、药代动力学及初步药效。
[Translation] To evaluate the safety, pharmacokinetics and preliminary efficacy of subcutaneous long-acting human erythrocyte growth stimulating hormone injection in the treatment of chronic dialysis renal anemia.
100 Clinical Results associated with Shanghai Qiangbang Biological Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Qiangbang Biological Technology Co., Ltd.
100 Deals associated with Shanghai Qiangbang Biological Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Qiangbang Biological Technology Co., Ltd.